Hepatic Encephalopathy

被引：61
|
作者：
Khungar, Vandana [1 ,2 ]
Poordad, Fred [1 ,3 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[3] Cedars Sinai Med Ctr, Dept Surgey, Los Angeles, CA 90048 USA
来源：
CLINICS IN LIVER DISEASE | 2012年 / 16卷 / 02期
关键词：
Hepatic encephalopathy; Minimal hepatic encephalopathy; Overt hepatic encephalopathy; Treatment; INTRAHEPATIC PORTOSYSTEMIC SHUNT; ORNITHINE-L-ASPARTATE; PORTAL-SYSTEMIC ENCEPHALOPATHY; RANDOMIZED CONTROLLED-TRIAL; ORAL ZINC SUPPLEMENTATION; QUALITY-OF-LIFE; DOUBLE-BLIND; RIFAXIMIN TREATMENT; LIVER-CIRRHOSIS; NEUROPSYCHOLOGICAL CHARACTERIZATION;
D O I：
10.1016/j.cld.2012.03.009
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatic encephalopathy (HE) represents a continuum of transient and reversible neurologic and psychiatric dysfunction. It is a reversible state of impaired cognitive function or altered consciousness in patients with liver disease or portosystemic shunting. Over the last several years, high-quality studies have been conducted on various pharmacologic therapies for HE; as more data emerge, it is hoped that HE will become a more easily treated complication of decompensated liver disease. In the interim, it is important that physicians continue to screen for minimal HE and treat patients early in addition to continuing to provide current treatments of overt HE.
引用
收藏
页码：301 / +
页数：21
相关论文
共 50 条
  • [41] Role of rifaximin in the treatment of hepatic encephalopathy
    Sanchez-Delgado, Jordi
    Miquel, Mireia
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (04): : 282 - 292
  • [42] Pathophysiology, diagnosis, and management of hepatic encephalopathy
    Sheasgreen, Christopher
    Lu, Lucy
    Patel, Ameen
    INFLAMMOPHARMACOLOGY, 2014, 22 (06) : 319 - 326
  • [43] The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy A Systematic Review
    Horner, Daniela Viramontes
    Avery, Amanda
    Stow, Ruth
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2017, 51 (04) : 312 - 323
  • [44] Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
    Moran, Segundo
    Lopez-Sanchez, Marlene
    del Pilar Milke-Garcia, Maria
    Rodriguez-Leal, Gustavo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (22) : 3050 - 3063
  • [45] Minimal hepatic encephalopathy
    Stinton, Laura M.
    Jayakumar, Saumya
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 27 (10) : 572 - 574
  • [46] Quality of life in patients with minimal hepatic encephalopathy
    Ridola, Lorenzo
    Nardelli, Silvia
    Gioia, Stefania
    Riggio, Oliviero
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (48) : 5446 - 5453
  • [47] IMPORTANCE OF NUTRITIONAL SUPPORT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY
    Jurado Garcia, J.
    Costan Rodero, G.
    Calanas-Continente, A.
    NUTRICION HOSPITALARIA, 2012, 27 (02) : 372 - 381
  • [48] Advances in the evaluation and management of minimal hepatic encephalopathy
    Montgomery J.Y.
    Bajaj J.S.
    Current Gastroenterology Reports, 2011, 13 (1) : 26 - 33
  • [49] Cerebral Aspects of Portal Hypertension Hepatic Encephalopathy
    Thomsen, Karen Louise
    Sorensen, Michael
    Kjaergaard, Kristoffer
    Eriksen, Peter Lykke
    Lauridsen, Mette Munk
    Vilstrup, Hendrik
    CLINICS IN LIVER DISEASE, 2024, 28 (03) : 541 - 554
  • [50] Hepatic Encephalopathy: Current Thoughts on Pathophysiology and Management
    Sen, Barun Kumar
    Pan, Kausik
    Chakravarty, Ambar
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2025, 25 (01)
12345